Story at glance:

The US FDA is investigating a potential link between a commonly used class of diabetes drugs known as DPP-4 inhibitors and pre-cancerous changes to the pancreas. Additionally, previous studies have also indicated a connection of thyroid, colon, melanoma, and prostate cancer

• FDA is adding a new heart-risk Continue reading →